Latest headcount
10,800
YoY change
+1.9%
Headcount CAGR
+3.5%
Revenue / employee
$285K
Employee count history for West Pharmaceutical Services
| Fiscal year | Employees |
|---|---|
| 1994 | 3,680 |
| 1995 | 5,210 |
| 1996 | 5,040 |
| 1997 | 4,800 |
| 1998 | 4,800 |
| 1999 | 4,800 |
| 2000 | 4,700 |
| 2001 | 3,960 |
| 2002 | 4,140 |
| 2003 | 4,365 |
| 2004 | 4,350 |
| 2005 | 5,570 |
| 2006 | 6,323 |
| 2007 | 6,478 |
| 2008 | 6,300 |
| 2009 | 6,408 |
| 2010 | 6,600 |
| 2011 | 6,300 |
| 2012 | 6,700 |
| 2013 | 6,900 |
| 2014 | 7,000 |
| 2015 | 7,100 |
| 2016 | 7,300 |
| 2017 | 7,500 |
| 2018 | 7,700 |
| 2019 | 8,200 |
| 2020 | 9,200 |
| 2021 | 10,065 |
| 2022 | 10,700 |
| 2023 | 10,600 |
| 2024 | 10,600 |
| 2025 | 10,800 |
Revenue per employee for West Pharmaceutical Services
Annual revenue divided by reported headcount, normalized to US dollars.
| Fiscal year | Revenue per employee (USD) |
|---|---|
| 1994 | $99.2K |
| 1995 | $79.3K |
| 1996 | $91K |
| 1997 | $94.3K |
| 1998 | $93.7K |
| 1999 | $97.7K |
| 2000 | $91.5K |
| 2001 | $100K |
| 2002 | $101K |
| 2003 | $112K |
| 2004 | $125K |
| 2005 | $126K |
| 2006 | $144K |
| 2007 | $157K |
| 2008 | $167K |
| 2009 | $165K |
| 2010 | $167K |
| 2011 | $189K |
| 2012 | $189K |
| 2013 | $198K |
| 2014 | $203K |
| 2015 | $197K |
| 2016 | $207K |
| 2017 | $213K |
| 2018 | $223K |
| 2019 | $225K |
| 2020 | $233K |
| 2021 | $281K |
| 2022 | $270K |
| 2023 | $278K |
| 2024 | $273K |
| 2025 | $285K |
Earnings per employee for West Pharmaceutical Services
Annual net income divided by reported headcount, normalized to US dollars; years with a net loss dip below zero.
| Fiscal year | Earnings per employee (USD) |
|---|---|
| 1994 | $7.42K |
| 1995 | $5.51K |
| 1996 | $3.25K |
| 1997 | $9.25K |
| 1998 | $1.4K |
| 1999 | $8.06K |
| 2000 | $340.43 |
| 2001 | -$1.31K |
| 2002 | $4.44K |
| 2003 | $7.31K |
| 2004 | $4.46K |
| 2005 | $8.19K |
| 2006 | $10.6K |
| 2007 | $10.9K |
| 2008 | $13.7K |
| 2009 | $11.3K |
| 2010 | $9.89K |
| 2011 | $12K |
| 2012 | $12K |
| 2013 | $16.3K |
| 2014 | $18.2K |
| 2015 | $13.5K |
| 2016 | $19.7K |
| 2017 | $20.1K |
| 2018 | $26.9K |
| 2019 | $29.5K |
| 2020 | $37.6K |
| 2021 | $65.8K |
| 2022 | $54.8K |
| 2023 | $56K |
| 2024 | $46.5K |
| 2025 | $45.7K |
Employee count history for West Pharmaceutical Services (WST)
Annual figures come from annual reports (10-K, or 20-F/40-F for foreign filers); interim rows reflect headcount disclosed in periodic filings. Year-over-year change compares each filing with the prior year's equivalent. Revenue and earnings per employee are annual figures normalized to US dollars.
- 202510,800+1.9%
- 202410,6000.0%
- 202310,600-0.9%
- 202210,700+6.3%
- 202110,065+9.4%
- 20209,200+12.2%
- 20198,200+6.5%
- 20187,700+2.7%
- 20177,500+2.7%
- 20167,300+2.8%
- 20157,100+1.4%
- 20147,000+1.4%
- 20136,900+3.0%
- 20126,700+6.3%
- 20116,300-4.5%
- 20106,600+3.0%
- 20096,408+1.7%
- 20086,300-2.7%
- 20076,478+2.5%
- 20066,323+13.5%
- 20055,570+28.0%
- 20044,350-0.3%
- 20034,365+5.4%
- 20024,140+4.5%
- 20013,960-15.7%
- 20004,700-2.1%
- 19994,8000.0%
- 19984,8000.0%
- 19974,800-4.8%
- 19965,040-3.3%
- 19955,210+41.6%
- 19943,680—
About West Pharmaceutical Services's employee count
West Pharmaceutical Services (WST) employed 10,800 people in fiscal year 2025, based on its most recent annual report. That headcount grew by +200 (+1.9%) from 10,600 a year earlier.
Across the 1994–2025 period, the company's reported workforce went from 3,680 to 10,800 employees — a compound annual growth rate (CAGR) of +3.5% per year.
West Pharmaceutical Services generated about $285K of revenue and $45.7K of net income per employee in its latest annual period. Revenue and earnings per employee gauge how efficiently a company turns headcount into output, and are most telling when tracked over time or compared with peers in the same industry.
Frequently asked questions
Test yourself on WST
Employees — 10 rounds, every one of them WST against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.34% TTM
- Dividend Profile0.26% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.